First Potential Drug to Treat Underlying Cause of Fatal Disease under Review by FDA
BETHESDA, Md., Nov. 1, 2011 /PRNewswire-USNewswire/ -- For the first time, a drug that's designed to treat the underlying cause of cystic fibrosis, Kalydeco™ (ivacaftor), is under review by the...